OptimizeRx
OPRX
#8107
Rank
A$0.39 B
Marketcap
A$21.44
Share price
-2.80%
Change (1 day)
168.50%
Change (1 year)

OptimizeRx (OPRX) - Cash on Hand

Cash on Hand as of September 2025 : A$29.38 Million

According to OptimizeRx's latest financial reports the company has A$29.38 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

OptimizeRx - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$21.51 M5.8%
2023-12-31A$20.33 M-81.34%
2022-12-31A$0.10 B-6.73%
2021-12-31A$0.11 B754.02%
2020-12-31A$13.67 M-49.21%
2019-12-31A$26.92 M112.8%
2018-12-31A$12.65 M92.84%
2017-12-31A$6.56 M-32.77%
2016-12-31A$9.75 M-13.38%
2015-12-31A$11.26 M167.5%
2014-12-31A$4.21 M235.96%
2013-12-31A$1.25 M358.31%
2012-12-31A$0.27 M-70.76%
2011-12-31A$0.93 M-25.65%
2010-12-31A$1.25 M72.2%
2009-12-31A$0.73 M-79.4%
2008-12-31A$3.54 M2189.98%
2007-12-31A$0.15 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Brightcove
BCOV
A$40.59 M 38.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Park City Group
PCYG
A$35.67 M 21.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LivePerson
LPSN
A$0.24 B 729.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Crexendo
CXDO
A$43.01 M 46.39%๐Ÿ‡บ๐Ÿ‡ธ USA